Clinical Trial Update: Low-Titer O Positive Whole Blood Versus Component Therapy for Emergent Transfusion in Trauma Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing low-titer O-positive whole blood to component therapy for emergent transfusion in trauma patients has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blood Loss Anemia
• Hemorrhagic Shock
• Traumatic Brain Injury

Snippet

Sponsor: Loma Linda University | Conditions: Hemorrhagic Shock, Acute Blood Loss Anemia | Phase 3 | Status: COMPLETED | Results posted: 2025-08-08